Ma C, Awosika JA, Monge C, Coffman-D'Annibale K, et al. Altering the gut microbiome and tumor microenvironment in advanced liver cancer: A phase II study of nivolumab, tadalafil and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorec Cancer Lett 2025;632:217975.
PMID: 40789510